Log in
Enquire now
‌

US Patent 9688967 Bacteria engineered to treat diseases associated with hyperammonemia

Patent 9688967 was granted and assigned to Synlogic on June, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating disorders associated with hyperammonemia are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9688967 Bacteria engineered to treat diseases associated with hyperammonemia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.